Want to see TELA full AI Analyst Report?
Total Valuation
TELA Bio has a market cap or net worth of $51.46M. The enterprise value is $69.25M.
Market Cap$51.46M
Enterprise Value$69.25M
Share Statistics
TELA Bio has 45,143,410 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,143,410
Owned by Insiders21.97%
Owned by Institutions50.01%
Financial Efficiency
TELA Bio’s return on equity (ROE) is -6.15 and return on invested capital (ROIC) is -53.21%.
Return on Equity (ROE)-6.15
Return on Assets (ROA)-0.48
Return on Invested Capital (ROIC)-53.21%
Return on Capital Employed (ROCE)-0.53
Revenue Per Employee368.23K
Profits Per Employee-178.12K
Employee Count218
Asset Turnover0.99
Inventory Turnover2.35
Valuation Ratios
The current PE Ratio of TELA Bio is ―. TELA Bio’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.69
PB Ratio8.78
Price to Fair Value8.78
Price to FCF-1.93
Price to Operating Cash Flow-2.10
PEG Ratio0.04
Income Statement
In the last 12 months, TELA Bio had revenue of 80.28M and earned -38.83M in profits. Earnings per share was -0.83.
Revenue80.28M
Gross Profit54.34M
Operating Income-33.76M
Pretax Income-38.60M
Net Income-38.83M
EBITDA-32.35M
Earnings Per Share (EPS)-0.83
Cash Flow
In the last 12 months, operating cash flow was -31.14M and capital expenditures -480.00K, giving a free cash flow of -31.62M billion.
Operating Cash Flow-31.14M
Free Cash Flow-31.62M
Free Cash Flow per Share-0.70
Dividends & Yields
TELA Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.90
52-Week Price Change-25.00%
50-Day Moving Average0.89
200-Day Moving Average0.87
Relative Strength Index (RSI)53.95
Average Volume (3m)302.64K
Important Dates
TELA Bio upcoming earnings date is Nov 11, 2026, Before Open (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
TELA Bio as a current ratio of 4.20, with Debt / Equity ratio of -356.81%
Current Ratio4.20
Quick Ratio3.59
Debt to Market Cap1.00
Net Debt to EBITDA-0.15
Interest Coverage Ratio-6.44
Taxes
In the past 12 months, TELA Bio has paid 230.00K in taxes.
Income Tax230.00K
Effective Tax Rate>-0.01
Enterprise Valuation
TELA Bio EV to EBITDA ratio is -1.86, with an EV/FCF ratio of -2.10.
EV to Sales0.75
EV to EBITDA-1.86
EV to Free Cash Flow-2.10
EV to Operating Cash Flow-2.13
Balance Sheet
TELA Bio has $30.42M in cash and marketable securities with $56.61M in debt, giving a net cash position of -$26.19M billion.
Cash & Marketable Securities$30.42M
Total Debt$56.61M
Net Cash-$26.19M
Net Cash Per Share-$0.58
Tangible Book Value Per Share$0.11
Margins
Gross margin is 67.81%, with operating margin of -42.05%, and net profit margin of -48.37%.
Gross Margin67.81%
Operating Margin-42.05%
Pretax Margin-48.09%
Net Profit Margin-48.37%
EBITDA Margin-40.29%
EBIT Margin-41.55%
Analyst Forecast
The average price target for TELA Bio is $1.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$1.75
Price Target Upside150.00% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast6.09%
EPS Growth Forecast30.65%